Ultragenyx Pharmaceu (RARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RARE | KRYS | ALKS | ||
| Company | Ultragenyx Pharmaceu | Krystal Biotech Inc | Alkermes Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 58.54 | 187.42 | 28.26 | ||
| High | 59.90 | 190.96 | 28.47 | ||
| Low | 58.21 | 183.98 | 27.99 | ||
| Last | 58.78 | 184.48 | 28.35 | ||
| Change | +1.08 | +1.74 | +0.52 | ||
| % Change | +1.87% | +0.95% | +1.87% | ||
| Volume | 558,300 | 365,600 | 1,127,300 | ||
| 20-Day Average Volume | 621,905 | 237,090 | 1,341,460 | ||
| Previous Close | 57.70 | 182.74 | 27.83 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 57.08 | 192.73 | 27.70 | ||
| 20-Day Raw Stochastic | 72.01% | 12.18% | 88.83% | ||
| 20-Day Relative Strength | 65.78% | 45.61% | 59.13% | ||
| Weighted Alpha | +68.39 | +27.03 | +3.71 | ||
| Today's Opinion | 88% Buy | 40% Buy | 80% Buy | ||
| Previous Opinion | 88% Buy | 40% Buy | 72% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.64% since 09/12/24 | -5.70% since 09/12/24 | +6.74% since 09/12/24 | ||
| Low | 57.44 on 09/18/24 | 182.18 on 09/18/24 | 26.75 on 09/13/24 | ||
| High | 60.37 on 09/16/24 | 203.29 on 09/16/24 | 28.47 on 09/17/24 | ||
| 1-Month | |||||
| %Chg | +9.30% since 08/19/24 | -7.15% since 08/19/24 | +0.43% since 08/19/24 | ||
| Low | 52.63 on 08/20/24 | 181.36 on 09/06/24 | 25.65 on 09/10/24 | ||
| High | 60.37 on 09/16/24 | 206.97 on 08/28/24 | 28.69 on 08/27/24 | ||
| 3-Month | |||||
| %Chg | +57.08% since 06/18/24 | +6.64% since 06/18/24 | +16.09% since 06/18/24 | ||
| Low | 37.27 on 06/20/24 | 164.81 on 08/05/24 | 22.90 on 07/10/24 | ||
| High | 60.37 on 09/16/24 | 219.34 on 07/26/24 | 28.95 on 07/26/24 | ||
| 6-Month | |||||
| %Chg | +25.06% since 03/19/24 | +10.47% since 03/19/24 | +2.35% since 03/19/24 | ||
| Low | 37.02 on 06/18/24 | 144.00 on 05/06/24 | 22.90 on 07/10/24 | ||
| High | 60.37 on 09/16/24 | 219.34 on 07/26/24 | 28.95 on 07/26/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,796,775 | 5,218,689 | 4,709,421 | ||
| Shares Outstanding, K | 83,133 | 28,558 | 169,221 | ||
| Annual Sales | 434,250,000 | 50,700,000 | 1,663,410,000 | ||
| Annual Net Income | -606,640,000 | 10,930,000 | 355,760,000 | ||
| Last Quarter Sales | 147,030,000 | 70,280,000 | 399,130,000 | ||
| Last Quarter Net Income | -131,600,000 | 15,570,000 | 91,360,000 | ||
| 60-Month Beta | 0.56 | 0.82 | 0.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.52 on 08/01/24 | 0.86 on 08/05/24 | 0.72 on 07/24/24 | ||
| Latest Earnings Date | 11/07/24 | 11/04/24 | 10/23/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 363.96 | 16.03 | ||